207 related articles for article (PubMed ID: 3288084)
1. Immunotherapy of multiple sclerosis.
Weiner HL; Hafler DA
Ann Neurol; 1988 Mar; 23(3):211-22. PubMed ID: 3288084
[TBL] [Abstract][Full Text] [Related]
2. Immunopathogenesis and immunotherapy of multiple sclerosis.
Hemmer B; Nessler S; Zhou D; Kieseier B; Hartung HP
Nat Clin Pract Neurol; 2006 Apr; 2(4):201-11. PubMed ID: 16932551
[TBL] [Abstract][Full Text] [Related]
3. The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease?
Weiner HL
Ann Neurol; 2009 Mar; 65(3):239-48. PubMed ID: 19334069
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapeutic approaches in multiple sclerosis.
Adorini L
J Neurol Sci; 2004 Aug; 223(1):13-24. PubMed ID: 15261555
[TBL] [Abstract][Full Text] [Related]
5. Antigen-specific therapies in multiple sclerosis.
Sospedra M; Martin R
Int Rev Immunol; 2005; 24(5-6):393-413. PubMed ID: 16318988
[TBL] [Abstract][Full Text] [Related]
6. Therapy for multiple sclerosis.
Weiner HL; Hohol MJ; Khoury SJ; Dawson DM; Hafler DA
Neurol Clin; 1995 Feb; 13(1):173-96. PubMed ID: 7739502
[TBL] [Abstract][Full Text] [Related]
7. Antigen-specific therapies in multiple sclerosis: going beyond proteins and peptides.
Fontoura P; Garren H; Steinman L
Int Rev Immunol; 2005; 24(5-6):415-46. PubMed ID: 16318989
[TBL] [Abstract][Full Text] [Related]
8. The immunopathogenesis of multiple sclerosis.
Prat E; Martin R
J Rehabil Res Dev; 2002; 39(2):187-99. PubMed ID: 12051463
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
10. [Immunomodulatory therapy in multiple sclerosis].
Csépány T; Bereczki D
Ideggyogy Sz; 2004 Nov; 57(11-12):401-16. PubMed ID: 15662768
[TBL] [Abstract][Full Text] [Related]
11. Multiple sclerosis. II. A critical assessment of immunotherapy.
Durelli L; Bergamini L
Riv Neurol; 1989; 59(5):191-201. PubMed ID: 2483962
[TBL] [Abstract][Full Text] [Related]
12. Future immunotherapies in multiple sclerosis.
Blevins G; Martin R
Semin Neurol; 2003 Jun; 23(2):147-58. PubMed ID: 12894380
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapeutics of multiple sclerosis.
Durelli L
Acta Neurol (Napoli); 1991 Oct; 13(5):467-75. PubMed ID: 1723242
[TBL] [Abstract][Full Text] [Related]
14. Immunopathogenesis and immunotherapeutic approaches in multiple sclerosis.
Lim ET; Giovannoni G
Expert Rev Neurother; 2005 May; 5(3):379-90. PubMed ID: 15938671
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of multiple sclerosis--2. Application of a new immunological basic research is close].
Svenningsson A; Andersson M; Olsson T
Lakartidningen; 1998 Dec; 95(49):5631-5. PubMed ID: 9863301
[TBL] [Abstract][Full Text] [Related]
16. [Recent progress in treatment for multiple sclerosis].
Kira J
Rinsho Shinkeigaku; 2000 Dec; 40(12):1261-3. PubMed ID: 11464473
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic immunomodulation in neurology: from hope to reality. Exemplified by multiple sclerosis].
Schluep M; Regli F
Praxis (Bern 1994); 1995 Sep; 84(38):1021-4. PubMed ID: 7481299
[TBL] [Abstract][Full Text] [Related]
18. Overview of the rationale for immunomodulating therapies in multiple sclerosis.
Lisak RP
Neurology; 1988 Jul; 38(7 Suppl 2):5-8. PubMed ID: 3290714
[TBL] [Abstract][Full Text] [Related]
19. The immunological basis for treatment of multiple sclerosis.
Holmøy T; Vartdal F
Scand J Immunol; 2007 Oct; 66(4):374-82. PubMed ID: 17850581
[TBL] [Abstract][Full Text] [Related]
20. Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination.
Hermans G; Denzer U; Lohse A; Raus J; Stinissen P
J Autoimmun; 1999 Sep; 13(2):233-46. PubMed ID: 10479392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
